(VIANEWS) - CRISPR Therapeutics AG (CRSP), Netlist (NLST), Inari Medical (NARI) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. CRISPR Therapeutics AG (CRSP)
473% sales growth and 25.41% return on equity
CRISPR Therapeutics AG, a gene editing company, focuses on developing transformative gene-based medicines for serious human diseases.
CRISPR Therapeutics AG's sales growth this year is expected to be 119363% and a negative 95.3% for next year.
Year-on-year quarterly revenue growth grew by 2046950%, now sitting on 901.76M for the twelve trailing months.
Volume
Today's last reported volume for CRISPR Therapeutics AG is 1592740 which is 25.44% above its average volume of 1269680.
CRISPR Therapeutics AG's sales growth for the next quarter is 473%. The company's growth estimates for the current quarter and the next is a negative 33.3% and negative -20.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 25.41%.
Volatility
CRISPR Therapeutics AG's last day, last week, and last month's current volatility was 4.52%, 2.59%, and 2.49%, respectively.
CRISPR Therapeutics AG's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 5.18% (day), 4.18% (last week), and 4.34% (last month), respectively.
CRISPR Therapeutics AG's Stock Yearly Top and Bottom Value
CRISPR Therapeutics AG's stock is valued at $95.46 at 11:22 EST, way under its 52-week high of $220.20 and way higher than its 52-week low of $85.00.
CRISPR Therapeutics AG's Moving Average
CRISPR Therapeutics AG's value is under its 50-day moving average of $105.92 and way below its 200-day moving average of $120.09.2. Netlist (NLST)
122.2% sales growth and 48.3% return on equity
Netlist, Inc. designs, manufactures, and sells modular memory subsystems for the server, high-performance computing, and communications markets worldwide.
Netlist's sales growth this year is anticipated to be 183.7% and a negative 6.7% for next year.
Year-on-year quarterly revenue growth grew by 161.9%, now sitting on 117.49M for the twelve trailing months.
Volume
Today's last reported volume for Netlist is 470334 which is 53.19% below its average volume of 1004990.
Netlist's sales growth for the next quarter is 122.2%. The company's growth estimates for the present quarter and the next is a negative 0% and 50%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 48.3%.
Volatility
Netlist's last day, last week, and last month's current volatility was 0.42%, 3.74%, and 3.99%, respectively.
Netlist's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.75% (day), 7.35% (last week), and 7.26% (last month), respectively.
Netlist's Stock Yearly Top and Bottom Value
Netlist's stock is valued at $7.16 at 11:22 EST, way below its 52-week high of $10.20 and way higher than its 52-week low of $0.46.
Netlist's Moving Average
Netlist's value is way above its 50-day moving average of $6.23 and way higher than its 200-day moving average of $4.97.3. Inari Medical (NARI)
41.8% sales growth and 12.33% return on equity
Inari Medical, Inc., a commercial-stage medical device company, focuses on developing products to treat and transform the lives of patients suffering from venous diseases in the United States.
Inari Medical's sales growth this year is anticipated to be 81.3% and 25.8% for next year.
Year-on-year quarterly revenue growth grew by 149.9%, now sitting on 208.18M for the twelve trailing months.
Volume
Today's last reported volume for Inari Medical is 282728 which is 49.59% below its average volume of 560862.
Inari Medical's sales growth for the next quarter is 41.8%. The company's growth estimates for the current quarter and the next is a negative 108.3% and negative -69.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.33%.
Volatility
Inari Medical's last day, last week, and last month's current volatility was 0.83%, 0.86%, and 1.45%, respectively.
Inari Medical's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.69% (day), 2.61% (last week), and 3.43% (last month), respectively.
Inari Medical's Stock Yearly Top and Bottom Value
Inari Medical's stock is valued at $90.00 at 11:22 EST, way under its 52-week high of $127.42 and way above its 52-week low of $62.12.
Inari Medical's Moving Average
Inari Medical's value is above its 50-day moving average of $83.02 and above its 200-day moving average of $87.92.4. Casella Waste Systems (CWST)
12.3% sales growth and 34.13% return on equity
Casella Waste Systems, Inc., together with its subsidiaries, operates as a vertically integrated solid waste services company in the northeastern United States.
Casella Waste Systems's sales growth this year is expected to be 11.6% and 9.8% for next year.
Year-on-year quarterly revenue growth grew by 19.4%, now sitting on 847.61M for the twelve trailing months.
Volume
Today's last reported volume for Casella Waste Systems is 240705 which is 21.91% above its average volume of 197432.
Casella Waste Systems's sales growth for the next quarter is 12.3%. The company's growth estimates for the present quarter and the next is 5.9% and negative 0%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 34.13%.
Volatility
Casella Waste Systems's last day, last week, and last month's current volatility was 1.10%, 2.03%, and 1.03%, respectively.
Casella Waste Systems's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.59% (day), 3.04% (last week), and 1.98% (last month), respectively.
Casella Waste Systems's Stock Yearly Top and Bottom Value
Casella Waste Systems's stock is valued at $85.99 at 11:22 EST, under its 52-week high of $88.00 and way higher than its 52-week low of $53.43.